Shouyao Holdings (Beijing) Co. Ltd. A - Asset Resilience Ratio
Shouyao Holdings (Beijing) Co. Ltd. A (688197) has an Asset Resilience Ratio of 79.76% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 688197 net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2019–2025)
This chart shows how Shouyao Holdings (Beijing) Co. Ltd. A's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see 688197 current and non-current assets.
Liquid Assets Composition Over Time
This chart breaks down Shouyao Holdings (Beijing) Co. Ltd. A's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read Shouyao Holdings (Beijing) Co. Ltd. A debt and liabilities for a breakdown of total debt and financial obligations.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥578.87 Million | 79.76% |
| Total Liquid Assets | CN¥578.87 Million | 79.76% |
Asset Resilience Insights
- Very High Liquidity: Shouyao Holdings (Beijing) Co. Ltd. A maintains exceptional liquid asset reserves at 79.76% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
Shouyao Holdings (Beijing) Co. Ltd. A Industry Peers by Asset Resilience Ratio
Compare Shouyao Holdings (Beijing) Co. Ltd. A's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Abivax SA
PA:ABVX |
Biotechnology | 2.58% |
|
Shanghai RAAS Blood Products Co Ltd Class A
SHE:002252 |
Biotechnology | 2.03% |
|
Neuren Pharmaceuticals Ltd
AU:NEU |
Biotechnology | 90.43% |
|
Lifecome Biochemistry Co Ltd
SHE:002868 |
Biotechnology | 4.69% |
|
Pulike Biological Engineering
SHG:603566 |
Biotechnology | 17.82% |
|
Rocket Pharmaceuticals Inc
NASDAQ:RCKT |
Biotechnology | 14.00% |
|
NEWRON PHARMACEUT. EO-20
XETRA:NP5 |
Biotechnology | 41.67% |
|
Upstream Bio, Inc.
NASDAQ:UPB |
Biotechnology | 64.70% |
Annual Asset Resilience Ratio for Shouyao Holdings (Beijing) Co. Ltd. A (2019–2025)
The table below shows the annual Asset Resilience Ratio data for Shouyao Holdings (Beijing) Co. Ltd. A.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 82.69% | CN¥654.26 Million ≈ $95.74 Million |
CN¥791.23 Million ≈ $115.78 Million |
+2.73pp |
| 2024-12-31 | 79.96% | CN¥737.41 Million ≈ $107.91 Million |
CN¥922.23 Million ≈ $134.95 Million |
+70.95pp |
| 2023-12-31 | 9.00% | CN¥100.14 Million ≈ $14.65 Million |
CN¥1.11 Billion ≈ $162.74 Million |
-13.94pp |
| 2019-12-31 | 22.94% | CN¥50.21 Million ≈ $7.35 Million |
CN¥218.89 Million ≈ $32.03 Million |
-- |
About Shouyao Holdings (Beijing) Co. Ltd. A
Shouyao Holdings (Beijing) Co., LTD. engages in the research, development, and production of drugs in China. The company offers drugs for oncology indications, including non-small cell lung cancer, lymphoma, hepatocellular carcinoma, pancreatic cancer, breast cancer, ovarian cancer, thyroid cancer, leukemia, and diabetes. The company was founded in 2016 and is headquartered in Beijing, China.